Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herbert Y Meltzer

Showing results (1-10 of 303) with videos related to

Pageof 31
Sort By:
CNS Spectrums|February 24, 2004
Beyond control of acute exacerbation: enhancing affective and cognitive outcomesHerbert Y Meltzer
Current Opinion in Pharmacology|March 17, 2004
What's atypical about atypical antipsychotic drugs?Herbert Y Meltzer
Handbook of Experimental Pharmacology|November 7, 2012
Serotonergic mechanisms as targets for existing and novel antipsychoticsHerbert Y Meltzer
Indian Journal of Psychiatry|January 6, 2011
Healy Redux : In response to HealyHerbert Y Meltzer
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Illuminating the molecular basis for some antipsychotic drug-induced metabolic burdenHerbert Y Meltzer
CNS Spectrums|October 12, 2004
Cognitive factors in schizophrenia: causes, impact, and treatmentHerbert Y Meltzer
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 13, 2008
Oakley Ray, 1931-2007Herbert Y Meltzer
The American Journal of Psychiatry|January 5, 2002
Action of atypical antipsychoticsHerbert Y Meltzer
Current Psychiatry Reports|July 20, 2002
Suicidality in schizophrenia: a review of the evidence for risk factors and treatment optionsHerbert Y Meltzer
Clinical Schizophrenia & Related Psychoses|September 26, 2012
Clozapine: balancing safety with superior antipsychotic efficacyHerbert Y Meltzer
Pageof 31

Showing results (1-10 of 303) with videos related to

Sort By:
Pageof 31
CNS Spectrums|February 24, 2004
Beyond control of acute exacerbation: enhancing affective and cognitive outcomesHerbert Y Meltzer
Current Opinion in Pharmacology|March 17, 2004
What's atypical about atypical antipsychotic drugs?Herbert Y Meltzer
Handbook of Experimental Pharmacology|November 7, 2012
Serotonergic mechanisms as targets for existing and novel antipsychoticsHerbert Y Meltzer
Indian Journal of Psychiatry|January 6, 2011
Healy Redux : In response to HealyHerbert Y Meltzer
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Illuminating the molecular basis for some antipsychotic drug-induced metabolic burdenHerbert Y Meltzer
CNS Spectrums|October 12, 2004
Cognitive factors in schizophrenia: causes, impact, and treatmentHerbert Y Meltzer
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 13, 2008
Oakley Ray, 1931-2007Herbert Y Meltzer
The American Journal of Psychiatry|January 5, 2002
Action of atypical antipsychoticsHerbert Y Meltzer
Current Psychiatry Reports|July 20, 2002
Suicidality in schizophrenia: a review of the evidence for risk factors and treatment optionsHerbert Y Meltzer
Clinical Schizophrenia & Related Psychoses|September 26, 2012
Clozapine: balancing safety with superior antipsychotic efficacyHerbert Y Meltzer
Pageof 31